Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users.

Hecht SS, Carmella SG, Stepanov I, Jensen J, Anderson A, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):732-5. doi: 10.1158/1055-9965.EPI-07-2843.

2.

Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.

Carmella SG, Borukhova A, Akerkar SA, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):113-20.

3.

Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.

Hecht SS, Carmella SG, Ye M, Le KA, Jensen JA, Zimmerman CL, Hatsukami DK.

Cancer Res. 2002 Jan 1;62(1):129-34.

4.

Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.

Murphy SE, Carmella SG, Idris AM, Hoffmann D.

Cancer Epidemiol Biomarkers Prev. 1994 Jul-Aug;3(5):423-8.

5.

Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.

Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, Stoner GD, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):521-5.

6.

Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.

Carmella SG, Le Ka KA, Upadhyaya P, Hecht SS.

Chem Res Toxicol. 2002 Apr;15(4):545-50.

PMID:
11952341
7.

Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.

Hecht SS, Stepanov I, Carmella SG.

Acc Chem Res. 2016 Jan 19;49(1):106-14. doi: 10.1021/acs.accounts.5b00472. Epub 2015 Dec 17.

8.

Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers.

Hecht SS, Chung FL, Richie JP Jr, Akerkar SA, Borukhova A, Skowronski L, Carmella SG.

Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):877-84.

9.

Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.

Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, Mooney M, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1567-72.

10.

Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco.

Hecht SS, Carmella SG, Edmonds A, Murphy SE, Stepanov I, Luo X, Hatsukami DK.

Tob Control. 2008 Apr;17(2):128-31. doi: 10.1136/tc.2007.023242.

11.

Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers.

Stepanov I, Upadhyaya P, Carmella SG, Feuer R, Jensen J, Hatsukami DK, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1764-73. doi: 10.1158/1055-9965.EPI-07-2844.

12.

Metabolism of a glucuronide conjugate of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats.

Atawodi SE, Michelsen K, Richter E.

Arch Toxicol. 1994;69(1):14-7.

PMID:
7717849
13.

Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.

Upadhyaya P, Kenney PM, Hochalter JB, Wang M, Hecht SS.

Carcinogenesis. 1999 Aug;20(8):1577-82.

PMID:
10426810
14.

Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites.

Hecht SS, Trushin N, Reid-Quinn CA, Burak ES, Jones AB, Southers JL, Gombar CT, Carmella SG, Anderson LM, Rice JM.

Carcinogenesis. 1993 Feb;14(2):229-36.

PMID:
8435864
15.

Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.

Richie JP Jr, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):783-90.

16.
17.
18.

Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children.

Hecht SS, Ye M, Carmella SG, Fredrickson A, Adgate JL, Greaves IA, Church TR, Ryan AD, Mongin SJ, Sexton K.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1109-16.

20.

Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.

Hecht SS, Carmella SG, Chen M, Dor Koch JF, Miller AT, Murphy SE, Jensen JA, Zimmerman CL, Hatsukami DK.

Cancer Res. 1999 Feb 1;59(3):590-6.

Supplemental Content

Support Center